BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15925982)

  • 1. Spectrophotometric skin measurements correlate with EORTC/RTOG-common toxicity criteria.
    Momm F; Bartelt S; Haigis K; Grosse-Sender A; Witucki G
    Strahlenther Onkol; 2005 Jun; 181(6):392-5. PubMed ID: 15925982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moist skin care can diminish acute radiation-induced skin toxicity.
    Momm F; Weissenberger C; Bartelt S; Henke M
    Strahlenther Onkol; 2003 Oct; 179(10):708-12. PubMed ID: 14566480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
    López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
    Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer.
    Freedman GM; Anderson PR; Li J; Eisenberg DF; Hanlon AL; Wang L; Nicolaou N
    Am J Clin Oncol; 2006 Feb; 29(1):66-70. PubMed ID: 16462506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?
    Röper B; Kaisig D; Auer F; Mergen E; Molls M
    Strahlenther Onkol; 2004 May; 180(5):315-22. PubMed ID: 15127162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
    Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenge of scoring radiation-induced lung toxicity.
    Faria SL; Aslani M; Tafazoli FS; Souhami L; Freeman CR
    Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):371-5. PubMed ID: 19345074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and severity of skin reactions in patients with breast cancer undergoing adjuvant radiotherapy, the usefulness of two assessment instruments - a pilot study.
    Sharp L; Johansson H; Landin Y; Moegelin IM; Bergenmar M
    Eur J Cancer; 2011 Dec; 47(18):2665-72. PubMed ID: 21775130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.
    Borgmann K; Hoeller U; Nowack S; Bernhard M; Röper B; Brackrock S; Petersen C; Szymczak S; Ziegler A; Feyer P; Alberti W; Dikomey E
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):256-64. PubMed ID: 18406889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term toxicity of an intraoperative radiotherapy boost using low energy X-rays during breast-conserving surgery.
    Kraus-Tiefenbacher U; Bauer L; Scheda A; Fleckenstein K; Keller A; Herskind C; Steil V; Melchert F; Wenz F
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):377-81. PubMed ID: 16887294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing measures of acute bowel toxicity in patients with prostate cancer treated with external beam radiation therapy.
    Muanza TM; Albert PS; Smith S; Godette D; Crouse NS; Cooley-Zgela T; Sciuto L; Camphausen K; Coleman CN; Ménard C
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1316-21. PubMed ID: 16029787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients.
    Goldner G; Tomicek B; Becker G; Geinitz H; Wachter S; Zimmermann F; Wachter-Gerstner N; Reibenwein J; Glocker S; Bamberg M; Feldmann H; Pötzi R; Molls M; Pötter R
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):78-83. PubMed ID: 17189064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
    Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience.
    Mussari S; Sabino Della Sala W; Busana L; Vanoni V; Eccher C; Zani B; Menegotti L; Tomio L
    Strahlenther Onkol; 2006 Oct; 182(10):589-95. PubMed ID: 17013572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy.
    Tsougos I; Mavroidis P; Rajala J; Theodorou K; Järvenpää R; Pitkänen MA; Holli K; Ojala AT; Lind BK; Hyödynmaa S; Kappas C
    Phys Med Biol; 2005 Aug; 50(15):3535-54. PubMed ID: 16030381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
    Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Three-dimensional conformal radiation therapy for prostate cancer in Hamamatsu Medical Center].
    Kanda T; Nakagomi K; Goto S; Iijima M
    Hinyokika Kiyo; 2007 Jan; 53(1):9-12. PubMed ID: 17310762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
    Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.